 Connection
Kevin Lillehei to Interleukin-2
This is a "connection" page, showing publications Kevin Lillehei has written about Interleukin-2.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.255 |
|
|
|
-
Kruse CA, Cepeda L, Owens B, Johnson SD, Stears J, Lillehei KO. Treatment of recurrent glioma with intracavitary alloreactive cytotoxic T lymphocytes and interleukin-2. Cancer Immunol Immunother. 1997 Oct; 45(2):77-87.
Score: 0.140
-
Lillehei KO, Johnson SD, McCleary EL, Mitchell DH, Schiltz PM, Kruse CA. Adjuvant adoptive immunotherapy for pediatric recurrent brain tumors. Online J Curr Clin Trials. 1993 Dec 29; Doc No 111:[806 words; 5 paragraphs].
Score: 0.027
-
Kruse CA, Mitchell DH, Kleinschmidt-DeMasters BK, Bellgrau D, Eule JM, Parra JR, Kong Q, Lillehei KO. Systemic chemotherapy combined with local adoptive immunotherapy cures rats bearing 9L gliosarcoma. J Neurooncol. 1993 Feb; 15(2):97-112.
Score: 0.025
-
Lillehei KO, Mitchell DH, Johnson SD, McCleary EL, Kruse CA. Long-term follow-up of patients with recurrent malignant gliomas treated with adjuvant adoptive immunotherapy. Neurosurgery. 1991 Jan; 28(1):16-23.
Score: 0.022
-
Kruse CA, Lillehei KO, Mitchell DH, Kleinschmidt-DeMasters B, Bellgrau D. Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take. Proc Natl Acad Sci U S A. 1990 Dec; 87(24):9577-81.
Score: 0.022
-
Kruse CA, Mitchell DH, Lillehei KO, Johnson SD, McCleary EL, Moore GE, Waldrop S, Mierau GW. Interleukin-2-activated lymphocytes from brain tumor patients. A comparison of two preparations generated in vitro. Cancer. 1989 Oct 15; 64(8):1629-37.
Score: 0.020
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|